Despite variations by age group and influenza virus type, the 2023-2024 influenza vaccine was protective against outpatient illness in pediatric and adult patients.

If you feel like you’ve seen more bouts of the flu this year, you’re not wrong! This flu season is more serious and deadly ...

Recommendations on the strain composition of influenza virus vaccines for the 2025-2026 US season have been issued by FDA.

A hypoallergenic therapeutic vaccine candidate for peanut allergy was safe and tolerable, according to a poster presented at ...

Very few humans have gone up against bird flu. But we've all dealt with seasonal flu for years. Some of our immune systems ...

Americans are facing the highest death toll from influenza since 2018, just as more people become vulnerable because of ...

Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak ® platform to develop drug-Fc conjugate (DFC) immunotherapies, today announced two upcoming ...

Forbes contributors publish independent expert analyses and insights. Dr. Judy Stone focuses her writing on infectious diseases.

Researchers at McMaster University have started a phase-2 clinical trial on a next-generation, inhaled COVID-19 vaccine. The AeroVax study, supported by $8M in funding from the Canadian Institutes ...

Through the Vaccine Safety Datalink, the CDC collaborates with 13 healthcare organizations across the US, including 11 that provide electronic health record data and two that provide expertise.A ...

The 2024-2025 COVID-19 and influenza vaccines provided protection against ED/UC, outpatient visits, and hospitalizations. In the 2024-2025 season, the COVID-19 vaccine provided additional ...

Cornell researchers have developed a new vaccine platform that could provide more robust, longer-lasting protection from both COVID-19 and influenza, and broader immunity to different flu strains. In ...